Results 51 to 60 of about 6,863 (182)

Interobserver Reproducibility of the Gleason Score and ISUP Grade in Prostate Cancers in Cameroon

Health Research in Africa
RÉSUMÉ Introduction. Le score de Gleason est le critère pronostique par excellence du cancer de la prostate. Il est impératif qu’il y ait une bonne reproductibilité du score de Gleason afin de permettre une prise en charge optimale des patients ...
Djapa christelle, Mendimi Nkodo JM, Mekeme Mekeme J, Kabeyene Clarisse, Mbassi Achille, Kamadjou Cyril, Tchuendem Josephine, Ndoumba Afouba Alice, Mout Ngankol, Sando Zacharie   +9 more
doaj   +1 more source

Comparing the effectiveness of prostate cancer screening protocols: European Association of Urology– and European Randomized Study of Screening for Prostate Cancer–based strategies

International Journal of Cancer, Volume 159, Issue 2, Page 432-439, 15 July 2026.
What's new? Although screening reduces prostate cancer mortality, concerns about overdiagnosis and unnecessary biopsies have given rise to more tailored strategies. The European Association of Urology (EAU) proposed a risk‐adapted screening strategy combining prostate‐specific antigen (PSA)‐based intervals, a risk calculator, and magnetic resonance ...
Zhenwei Yang, Luuk A. van Duuren, Monique J. Roobol, Nicole S. Erler, Dimitris Rizopoulos, Eveline A. M. Heijnsdijk   +5 more
wiley   +1 more source

Retroperitoneal lymph‐node dissection for isolated nodal recurrence of renal cell carcinoma after nephrectomy: Contemporary outcomes of a case series

BJUI Compass, Volume 7, Issue 7, July 2026.
Abstract Background and objective Isolated retroperitoneal lymph‐node (RPLN) recurrence after radical nephrectomy (RN) for renal cell carcinoma (RCC) is uncommon, and optimal management remains undefined. This study reports contemporary outcomes of retroperitoneal lymph‐node dissection (RPLND) for isolated nodal recurrence, including in patients ...
Alberto Costa Silva, Noel Clarke, Aziz Gulamhusein   +2 more
wiley   +1 more source

External validation of the European association of urology biochemical recurrence risk groups to predict mortality after radical prostatectomy or radiation therapy in a North American cohort

BJUI Compass, Volume 7, Issue 7, July 2026.
Abstract Objectives This study aimed to externally validate the European Association of Urology (EAU) biochemical recurrence (BCR) risk stratification in a North American population after radical prostatectomy (RP) and radiation therapy (RT), where validation remains lacking despite prior European and Asian validation.
Carlo Silvani, Alfonso Santangelo, Alex Stephens, Jack Considine, Shane Tinsley, Bassel Salka, Akshay Sood, Sebastiano Nazzani, Alberto Briganti, Andrea Salonia, Francesco Montorsi, Nicola Nicolai, Emanuele Montanari, Craig Rogers, Firas Abdollah   +14 more
wiley   +1 more source

Robotic Partial Nephrectomy: Different Surgical Approaches for Different Locations

Cancer Medicine, Volume 15, Issue 7, July 2026.
ABSTRACT Background The adoption of robotic partial nephrectomy has grown significantly over the past decade, prompting a debate on the merits of transperitoneal versus retroperitoneal surgical access. This study evaluated the association between surgical route (transperitoneal, TRPN; retroperitoneal, RRPN) and pentafecta achievement using a detailed ...
Le Yu, Xun Zhao, Peichen Duan, Fan Shu, Zhuo Liu, Hongxian Zhang, Fan Zhang, Ye Yan, Shudong Zhang   +8 more
wiley   +1 more source

Impact of Genomic Mutations on the Transcriptional Pathways and Tumor Microenvironment Landscape of Localized Early Prostate Cancer

The Prostate, Volume 86, Issue 10, Page 1103-1114, July 2026.
ABSTRACT Background The management of intermediate‐risk early prostate cancer (PCa) is challenging due to the difficulty in distinguishing indolent from aggressive tumors. This study explores the association between genomic alterations and the tumor and its microenvironment (TME) and implications for disease progression. Methods We performed multi‐omic
William Lautert‐Dutra, Camila M. Melo, Luiz P. Chaves, Francisco C. Souza, Vida Talebian, Cheryl Crozier, Mary Anne Quintayo, Linda Liao, Dan Dion, Fabiano P. Saggioro, Felipe S. Avante, Rodolfo B. dos Reis, Jeremy A. Squire, Jane Bayani   +13 more
wiley   +1 more source

Nodal maximum standardised uptake value improves PSMA‐PET/CT‐based nodal staging in intermediate‐ and high‐risk prostate cancer

BJU International, Volume 138, Issue 1, Page 133-143, July 2026.
Objectives To evaluate whether nodal maximum standardised uptake value (SUVmax) improves the positive predictive value (PPV) of prostate‐specific membrane antigen (PSMA) positron emission tomography (PET)/computerised tomography (CT) for detecting lymph node invasion (LNI) in prostate cancer (PCa), and to develop clinical decision tools to guide ...
Alexandra S. Bruins Slot, Vera Sweere, Joris G. Heetman, Rick Hermsen, Lieke Wever, Jules Lavalaye, Maarten Vinken, Clinton D. Bahler, Mark Tann, Claudia Kesch, Tugce Telli, Wolfgang P. Fendler, Peter Ka‐Fung Chiu, Kwan Kit Wu, Fabio Zattoni, Laura Evangelista, Francesco Ceci, Marcin Miszczyk, Pawel Rajwa, Akihiro Matsukawa, Tamás Fazekas, Francesco Barletta, Alberto Briganti, Francesco Montorsi, Giorgio Gandaglia, Jean‐Paul A. Van Basten, Harm H. E. Van Melick, Roderick C. N. Van den Bergh, Giancarlo Marra, Timo F. W. Soeterik, Matthijs J. V. Scheltema, on behalf of the European Association of Urology‐Young Academic Urologists (EAU‐YAU) Prostate Cancer Working Group   +31 more
wiley   +1 more source

Prostate‐specific membrane antigen (PSMA)‐PET‐avid prostate cancers show stronger PSMA immunohistochemistry staining on biopsy cores

BJU International, EarlyView.
Jonathon Carll, Henry Yen‐Cheng Pan, Nathan Lawrentschuk, Andrew Ryan   +3 more
wiley   +1 more source

Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022 classification

The Journal of Pathology: Clinical Research
Although several prognostic models have been developed for clear cell renal cell carcinoma (ccRCC), these are still suboptimal and there is a need to identify additional prognostic biomarkers.
Selena Odeh, Iryna Samarska, Andres Matoso, Marcella MLL Baldewijns, Christina A Hulsbergen‐van de Kaa, Axel Zur Hausen, Manon vanEngeland, Leo J Schouten, Kim M Smits   +8 more
doaj   +1 more source

Clinical Tools for Optimizing Therapeutic Decision-Making in Prostate Cancer: A Five-Year Retrospective Analysis

Life
The effective staging of prostate cancer is essential for optimizing treatment and predicting outcomes. This study assessed the correlation between detailed preoperative diagnostic scores and postoperative outcomes to evaluate the accuracy of cancer ...
Silviu Constantin Latcu, Alin Adrian Cumpanas, Vlad Barbos, Victor-Bogdan Buciu, Marius Raica, Flavia Baderca, Pusa Nela Gaje, Raluca Amalia Ceausu, Cristina-Stefania Dumitru, Dorin Novacescu, Talida Georgiana Cut, Ligia Petrica   +11 more
doaj   +1 more source